GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Molecular Transport Inc (NAS:AMTI) » Definitions » Price-to-Free-Cash-Flow

Applied Molecular Transport (Applied Molecular Transport) Price-to-Free-Cash-Flow : N/A (As of May. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Applied Molecular Transport Price-to-Free-Cash-Flow?

As of today (2024-05-05), Applied Molecular Transport's share price is $0.263. Applied Molecular Transport's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.54. Hence, Applied Molecular Transport's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Applied Molecular Transport's Price-to-Free-Cash-Flow or its related term are showing as below:

AMTI's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.89
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Applied Molecular Transport's Free Cash Flow per Share for the three months ended in Sep. 2023 was $-0.11. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.54.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -22.80% per year.

During the past 5 years, Applied Molecular Transport's highest 3-Year average Free Cash Flow per Share Growth Rate was -12.20% per year. The lowest was -22.80% per year. And the median was -17.50% per year.


Applied Molecular Transport Price-to-Free-Cash-Flow Historical Data

The historical data trend for Applied Molecular Transport's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Molecular Transport Price-to-Free-Cash-Flow Chart

Applied Molecular Transport Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
- - - - -

Applied Molecular Transport Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Applied Molecular Transport's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Applied Molecular Transport's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied Molecular Transport's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Applied Molecular Transport's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Applied Molecular Transport's Price-to-Free-Cash-Flow falls into.



Applied Molecular Transport Price-to-Free-Cash-Flow Calculation

Applied Molecular Transport's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.263/-1.542
=N/A

Applied Molecular Transport's Share Price of today is $0.263.
Applied Molecular Transport's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Applied Molecular Transport  (NAS:AMTI) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Applied Molecular Transport Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Applied Molecular Transport's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied Molecular Transport (Applied Molecular Transport) Business Description

Traded in Other Exchanges
N/A
Address
450 East Jamie Court, South San Francisco, CA, USA, 94080
Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.
Executives
Shawn Cross officer: Chief Financial Officer 1825 K STREET SUITE 510, WASHINGTON DC 20006
Mahmood Tahir Ph.d. director, officer: Chief Executive Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Brandon Hants officer: VP, Finance & Bus. Ops. 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Douglas A. Rich officer: Chief Technical Officer C/O KYTHERA BIOPHARMACEUTICALS, INC., 30930 RUSSELL RANCH ROAD, 3RD FLOOR, WESTLAKE VILLAGE CA 91362
Bittoo Kanwar officer: Chief Medical Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Mrsny Randall Ph.d. director, officer: Chief Scientific Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Aaron Vandevender director 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
David Lamond director C/O CORTEXYME, INC., 269 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Epiq Capital Group, Llc other: Managing member of 10% owner ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Chad Boeding other: CEO of Managing Member ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Charlene A. Banard director C/O APPLIED MOLECULAR TRANSPORT INC., 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO CA 94080
John W Smither director C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301
Epq Llc Amt Ps other: Owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtc Ps other: Owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtb Ps 10 percent owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521

Applied Molecular Transport (Applied Molecular Transport) Headlines